Enzyme vs Codatta — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Codatta trades at Rp127.11 (market cap Rp312,04M, Rp16,43M 24h volume). The key difference: Codatta is far larger — about 2.3× Enzyme's market cap, and Codatta's supply is capped (2,5B / 10B XNY (25%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Codatta for 4 Days on average.
| MLN | XNY | |
|---|---|---|
Market Cap | Rp134,13M | Rp312,04M |
Volume (24h) | Rp104,56M | Rp16,43M |
Circulating Supply | 3,3M MLN | 2,5B / 10B XNY (25%) |
Typical Hold Time | 29 Days | 4 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
XNY (Codatta) trades at Rp123.31 with a market cap of Rp309.92M, showing a bullish technical signal from moving averages while oscillators are neutral. The asset has a 25% circulating supply (2.5M of 10M max) and short average hold time of 4 days. Key levels show support at Rp120 and resistance at Rp126. No recent protocol updates or major ecosystem news were identified.
Overall outlook is cautiously optimistic due to technical bullishness, but limited by low circulation rate and minimal fundamental catalysts. Key opportunities include potential price movement toward resistance; major risks are low liquidity and lack of recent development activity impacting long-term adoption.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Codatta is a decentralized infrastructure protocol that converts human and AI-generated knowledge into ownable, royalty-generating digital assets. It enables contributors to fractionalize data and earn ongoing revenue streams. Operating across BNB Chain, Ethereum, and Solana, Codatta provides provenance tracking, licensing, and automated payouts as a plug-and-play backend for AI and DeSci ecosystems.
Read more on XNY →